MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

Home・Akcijų sąrašas・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

31.33 -0.03

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

30.42

Max

31.55

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-14M -81M
Pardavimai	75K 75K
Pelnas, tenkantis vienai akcijai	-1.22
Pelno marža	-108,422.667
Darbuotojai	198
EBITDA	-7.8M -81M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+71.85% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-06

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	472M 2.1B
Ankstesnė atidarymo kaina	31.36
Ankstesnė uždarymo kaina	31.33

Naujienos nuotaikos

By Acuity

100%

332 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

18.91 / 20.63 Palaikymas ir pasipriešinimas

Celldex Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-07 17:26; UTC

Svarbiausios naujienos

EIA Raises Oil-Price Forecasts as War in Middle East Continues

2026-04-07 23:55; UTC

Rinkos pokalbiai

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

2026-04-07 23:47; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Market Talk Roundup: Latest on U.S. Politics

2026-04-07 23:47; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

2026-04-07 23:44; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

2026-04-07 23:42; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-07 23:42; UTC

Rinkos pokalbiai

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

2026-04-07 23:37; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

2026-04-07 23:15; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

2026-04-07 23:04; UTC

Svarbiausios naujienos

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

2026-04-07 23:04; UTC

Svarbiausios naujienos

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

2026-04-07 23:03; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-04-07 23:03; UTC

Rinkos pokalbiai

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

2026-04-07 23:01; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

2026-04-07 22:58; UTC

Svarbiausios naujienos

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

2026-04-07 21:56; UTC

Įsigijimai, susijungimai, perėmimai

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

2026-04-07 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-04-07 20:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-07 19:45; UTC

Rinkos pokalbiai

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

2026-04-07 19:17; UTC

Svarbiausios naujienos

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

2026-04-07 19:16; UTC

Rinkos pokalbiai

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

2026-04-07 19:07; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-04-07 19:07; UTC

Rinkos pokalbiai

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

2026-04-07 18:41; UTC

Įsigijimai, susijungimai, perėmimai

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

2026-04-07 18:40; UTC

Įsigijimai, susijungimai, perėmimai

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

2026-04-07 18:39; UTC

Įsigijimai, susijungimai, perėmimai

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

2026-04-07 18:24; UTC

Svarbiausios naujienos

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

2026-04-07 17:08; UTC

Rinkos pokalbiai

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

2026-04-07 16:21; UTC

Svarbiausios naujienos

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

2026-04-07 16:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Celldex Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

71.85% į viršų

12 mėnesių prognozė

Vidutinis 53.91 USD 71.85%

Aukščiausias 90 USD

Žemiausias 24 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Celldex Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

Pirkti

Laikyti

Parduoti

Remiantis 12 analitikų, pateikusių Celldex Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

18.91 / 20.63Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.